1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Mark Stegall: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients Janssen Ad26.CoV2.S Vaccine, Reduction in Immunosuppression Medication, Maintenance in Immunosuppression Medication - Kidney Transplant Recipient | Phase 3 | Terminated | Mark Stegall | 468 | 2022-04-11 | 2025-09-15 |
COVID-19 (1)
Maintenance (1)
United States (1)